RNA-sequencing results as well as the experimental result in our study demonstrated that PRMT6 does not affect the mRNA level of CDKN1B in GBM cells, and PRMT6 attenuates the protein stability of CDKN1B by the ubiquitinated proteasome. Here, CDKN1B is linked to glioblastoma.